BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31087138)

  • 21. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
    Sakatani A; Sonohara F; Goel A
    Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axis.
    Gao Y; Liu C; Xu X; Wang Y; Jiang Y
    Anticancer Drugs; 2022 Jul; 33(6):553-563. PubMed ID: 35276696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
    Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Li T; Gao F; Zhang XP
    Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
    Zhao L; Chen H; Zhang Q; Ma J; Hu H; Xu L
    Cancer Chemother Pharmacol; 2022 May; 89(5):595-607. PubMed ID: 35312836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.
    Nakagawa Y; Kuranaga Y; Tahara T; Yamashita H; Shibata T; Nagasaka M; Funasaka K; Ohmiya N; Akao Y
    Cancer Sci; 2019 Aug; 110(8):2540-2548. PubMed ID: 31162779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
    Qin Y; Chen X; Liu Z; Tian X; Huo Z
    Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells.
    Zichittella C; Barreca MM; Cordaro A; Corrado C; Alessandro R; Conigliaro A
    BMC Cancer; 2022 May; 22(1):567. PubMed ID: 35596172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.
    Liu RL; Dong Y; Deng YZ; Wang WJ; Li WD
    Tumour Biol; 2015 Jul; 36(7):5011-9. PubMed ID: 25913620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of miR-650 leads to down-regulation of KISS1, a possible route involved in overcoming 5-FU resistance and induction of apoptosis in CRC cells in-vitro.
    Valizadeh M; Babaei E; Sharifi R; Yazdanbod A
    Mol Biol Rep; 2023 Aug; 50(8):6591-6599. PubMed ID: 37341919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.
    Ye L; Jiang T; Shao H; Zhong L; Wang Z; Liu Y; Tang H; Qin B; Zhang X; Fan J
    Mol Ther Nucleic Acids; 2017 Jun; 7():453-464. PubMed ID: 28624221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
    Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
    Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
    Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
    Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.